Anti-GITR agonist TRX518 in combination with gemcitabine in advanced solid cancers: Preliminary safety and efficacy from a multi-center phase Ib trial
Velcheti, V., Bauer, T., Luke, J., Rixe, O., Bajor, D., Naik, G.S., Sirard, C., Davar, D.
Published in Annals of oncology (01.12.2018)
Published in Annals of oncology (01.12.2018)
Get full text
Journal Article
Dkn-01 treated patients with recurrent epithelial endometrial (EEC) or ovarian (EOC) cancers which harbor Wnt activating mutations have longer progression-free survival and improved clinical benefit
Arend, R.C., Castro, C.M., Matulonis, U.A., Hamilton, E., Gunderson, C.C., Lybarger, K.S.S., Goodman, H.M., Duska, L.R., Mahdi, H., ElNaggar, A.C., Naik, G.S., Kagey, M., Barroilhet, L.M., Bradley, W.H., Sachdev, J.C., O'Malley, D.M., Sirard, C., Birrer, M.J.
Published in Gynecologic oncology (01.10.2020)
Published in Gynecologic oncology (01.10.2020)
Get full text
Journal Article